Will Omicron trigger another Economic Slowdown?

Published by Linda on

GT Molecular announces a highly sensitive wastewater testing service for the Omicron Coronavirus variant

GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels, has announced the upcoming release of its sensitive PCR tests to monitor the coronavirus Omicron variant, B.1.1.529. (Source- prnewswire)

Biocartis’ Idylla™ SARS-CoV-2 testing successfully detects Omicron variant

Biocartis Group NV announced that the company performed an in-silico analysis which concluded that the Idylla™ SARS-CoV-2 Test (CE-IVD) and the Idylla™ SARS-CoV-2/Flu/RSV1 Panel (CE-IVD) detect the currently available B.1.1.529/Omicron sequences, the new variant of concern causing COVID-19 disease. (Source- globenewswire)

Tevogen Bio has been granted a patent for the method of preparing COVID-19 peptide specific T cells, and methods of treating COVID-19 using CTL therapy

Tevogen Bio announced the issuance of a patent which significantly reinforces Tevogen’s intellectual property position in use of SARS-CoV-2 specific Cytotoxic CD8+ T Lymphocytes (CTL) immunotherapy for treatment of COVID-19. Dr. Neal Flomenberg, MD, said, our  therapeutic targets are not affected in the Delta variant and appear preserved in the Omicron variant as well. (Source- businesswire)

POSTECH team develops testing method to detect Omicron variant

A research team at Pohang University of Science and Technology (POSTECH) has developed a diagnostic technology to detect the Covid-19 variant Omicron in just 20 minutes. The researchers are preparing to apply for a patent for commercialization. (Source- koreabiomed)

Gb Sciences targets COVID-19 treatment as Omicron variant arrives

Gb Sciences has reported positive results from a study of its potential treatment for cytokine release syndrome (CRS), one of the most dangerous complications of COVID-19. With the arrival of Omicron variant, Gb Sciences plans to move quickly through the development stages for this novel CRS therapy. (Source- globenewswire)

Copper fresh masks to restrict the spread of Covid-19

The Copper fresh mask’s introduction, comes at an apt time, considering the detection of the Omicron variant just over two weeks ago. The masks offer dual-side protection with 99.9% bacterial filtration. The mask kills the virus just a few minutes after it touches the mask. (Source – iol.co)

GreenLight (ENVI) and IAVI begin work on Omicron variant-adapted COVID-19 vaccine candidate

GreenLight Biosciences (ENVI) and IAVI, a nonprofit scientific research organization announced work on a messenger RNA vaccine candidate to tackle the COVID-19 Omicron variant. GreenLight’s Covid-19 vaccine candidate will begin clinical trials in South Africa next year. (Source-  prnewswire)

Seegene’s new PCR test identifies the Omicron variant, its stealth version and all VOCs in a single tube

Seegene Inc. unveiled series of diagnostic test that detects the ever-changing COVID-19 variant landscape. The Novaplex™ SARS-CoV-2 variants VII assay addresses Omicron and its stealth version, as well as other variants. (Source-  prnewswire)


Linda

Linda, Lead Patent Scientist at DexPatent, is dedicated to aiding IP Counsel and Patent attorneys in Patent research and management. Her interests span from reading books to writing on subjects related to innovation, work, and life.

0 Comments

Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *

Explore Featured Articles

Competitive Intelligence: Fingerprint Detection In Portable Devices

Competitive Intelligence: Fingerprint Detection In Portable Devices

Facebook patents a new technology for an “authentic” robot eye

Facebook patents a new technology for an “authentic” robot eye

Video as a Prior Art

Video as a Prior Art

Centered Image

Patent Newz Box is a collection of carefully handpicked Patent & IP news items delivered fortnightly, straight to your inbox, It helps you to stay on top of Global Patent News.

fast
Consistent

DexPatent consistently delivers high-quality reports.

fast
Reliable

DexPatent is a trusted partner for many MNCs and law firms.

fast
Fast

DexPatent’s quick response shows we respect your time.

Get in touch with us

Get a Quote

Please check your answer
Schedule a Call

Schedule a Call